Gain Therapeutics Inc. (GANX)
NASDAQ · Healthcare
Gain Therapeutics Inc. Cash Flow 2020–2023
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | -18.5M | -18.9M | -18.9M | -14.7M | -12.4M | -3.2M |
| Depreciation & Amort. | 94,046 | 84,071 | 83,579 | 64,168 | 15,484 | 9,592 |
| Investing Activities | ||||||
| Capital Expenditure | — | — | — | — | 94,212 | 20,826 |
| Free Cash Flow | — | — | — | — | -12.5M | -3.3M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — |
Gain Therapeutics Inc. Cash Flow — FAQ
Gain Therapeutics Inc. (GANX) cash flow over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GANX's cash flow history?
The chart and table above show Gain Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.